Neurodegenerative diseases neurobiology, pathogenesis, and therapeutics
Neurodegenerative diseases are major contributors to disability and disease, with Alzheimer's and Parkinson's diseases the most prevalent. This major reference reviews the rapidly advancing knowledge of pathogenesis and treatment of neurodegenerative diseases in the context of a comprehens...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
Cambridge University Press
2005
|
| Schlagworte: | |
| Online-Zugang: | DE-12 DE-92 URL des Erstveröffentlichers |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Inhaltsangabe:
- Endogenous free radicals and antioxidants in the brain
- Biological oxidants and therapeutic antioxidants
- Mitochondria, metabolic inhibitors and neurodegeneration
- Excitoxicity and excitatory amino acid antagonists in chronic neurodegenerative diseases
- Glutamate transporters
- Calcium binding proteins in selective vulnerability of motor neurons
- Apoptosis in neurodegenerative diseases
- Neurotrophic factors
- Protein misfolding and cellular defense mechanisms in neurodegenerative diseases
- Neurodegenerative disease and the repair of oxidatively damaged DNA
- Compounds acting on ion channels
- The role of nitric oxide and PARP in neuronal cell death
- Copper and zinc in Alzheimer's disease and amyotrophic lateral sclerosis
- The role of inflammation in Alzheimer's disease neuropathology and clinical dementia. From epidemiology to treatment
- Selected genetically engineered models relevant to human neurodegenerative disease
- Friedreich's ataxia and other autosomal recessive ataxias
- Ataxia telangiectasia
- An approach to the patient with motor neuron dysfunction
- The genetics of amyotrophic lateral sclerosis
- Current and potential therapeutics in motor neuron diseases
- The hereditary spastic paraplegias
- Spinal and bulbar muscular atrophy (Kennedy's disease): a sex-limited, polyglutamine repeat expansion disorder
- Spinal muscular atrophies
- Western Pacific ALS/parkinsonism-dementia complex
- Huntington's disease
- Dentatorubral-pallidoluysian atrophy (DRPLA): model for Huntington's disease and other polyglutamine diseases
- Neurocanthocytosis
- Brain iron disorders
- Neurological aspects of Wilson's disease
- Disorders of the mitochondrial respiratory chain
- The neuropathology of Alzheimer's disease in the year 2005
- Genetics of Alzheimer's disease
- The role of [beta]-amyloid in Alzheimer's disease
- Treatment of Alzheimer's disease
- Dementia with Lewy bodies
- Frontotemporal lobar degeneration
- Frontotemporal dementia with parkinsonism linked to chromosome 17
- Prion diseases
- Approach to the patient presenting with parkinsonism
- Parkinson's disease
- Neuropathology of Parkinson's disease
- Genetics of parkinsonism
- Pathophysiology: biochemistry of Parkinson's disease
- Current and potential treatments of Parkinson's disease
- Current and potential treatments of Parkonson's disease
- Multiple system atrophy
- Progressive supranuclear palsy
- Corticobasal degeneration
- Approach to the patient with ataxia
- Autosomal dominant cerebellar ataxia
- Toxic animal models
- A genetic outline of the pathways to cell death in Alzheimer's disease, Parkinson's disease, frontal dementias and related disorders
- Neurophysiology of Parkinson's disease, levodopa-induced dyskinesias, dystonia, Huntington's disease and muyoclonus
- Structural and functional magnetic resonance imaging in neurodegenerative diseases
- PET/SPECT
- Magnetic resonance spectroscopy of neurodegenerative illness
- Gene therapy
- Stem cells and cell-based theapy in neurodegenerative disease
- Necessary methodological and stem cell advances for restoration of the dopaminergic system in Parkinson's disease patients
- Clinical aspects of normal aging
- Neuropathology of normal aging in cerebral cortex
- Mild cognitive impairment
- Alzheimer's disease: overview